Sleep Research and Affective Disorders

Mood Disorders: Clinical Management and Research Issues

Volumn , Issue , 2005, Pages 449-465

  Wilson, Sue J ^a   Nutt, David J ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Electroencephalography (EEG); Electrooculography (EOG); Measuring pharmacodynamic effects; Non REM sleep; REM alterations in depression; REM suppression; Sleep and major depression; Sleep disturbance; Slow wave sleep (SWS) abnormalities

Indexed keywords

EID: 84889458632     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/0470094281.ch15     Document Type: Chapter

References (48)

1. Agargun MY, Kara H, Solmaz M (1997a) Sleep disturbances and suicidal behavior in patients with major depression. J Clin Psychiatry 58 (6): 249-251.
2. Agargun MY, Kara H, Solmaz M (1997b) Subjective sleep quality and suicidality in patients with major depression. JPsychiatr Res 31 (3): 377-381.
3. Artigas F (1993) 5HTand antidepressants: new views from microdialysis studies. Trends Pharmacol Sci 14:262.
4. Artigas F, Perez V, Alvarez E (1994) Pindolol induces a rapid improvement of depressed patients treated with serotonin re-uptake inhibitors. Arch Gen Psychiatry 51:248-251.
5. Bakish D, Hooper CL, Thornton MD (1997) Fast onset: an open study of the treatment of major depressive disorder with nefazodone and pindolol combination therapy. Int Clin Psychopharmacol 12:91-97.
6. Bel N, Artigas F (1993) Chronic treatment with fluvoxamine increases extracellular serotonin in the frontal cortex but not in raphe nuclei. Synapse 15: 243-245.
7. Bell C, Wilson S, Rich A, Bailey J, Nutt D (2003) The effects on sleep architecture of pindolol, paroxetine and their combination in healthy volunteers. Psychopharmacology 166: 102-110.
8. Benca RM, Obermeyer WH,Thisted RA, GillinJC (1992) Sleep and psychiatric disorders. A meta-analysis. Arch GGen Psychiatry 49(8): 651-668.
9. Berger M, RiemannD (1993) REM sleep in depression-an overview. JSleepRes 2: 211-223.
10. Blier P, Bergeron R (1995) Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J Clin Psychopharmacol 15: 217-222.
11. Blier P, de Montigny C (1994) Current advances and trends in the treatment of depression. Trends Pharmacol Sci 15: 220-226.
12. Ciapparelli A, Gemignani A, Figura A, Guerrini I, Palagini L, Guazzelli M (1994) Effect of fluoxetine and clomipramine on EEG delta activity during sleep in major depression. J Sleep Res 3:415.
13. Dunleavy DLF, Brezinova V, Oswald I, Maclean AW, TinkerW (1972) Changes during weeks in effects of tricyclic drugs on the human sleeping brain. Brit J Psychiat 120: 663-672.
14. Ehlers CL, Havstad JW, Kupfer DJ (1996) Estimation of the time course of slow-wave sleep over the night in depressed patients: effects of clomipramine and clinical response. Biol Psychiatry 39(3): 171-181.
15. Emslie GJ, Rush AJ, Weinberg WA (1994) Sleep EEG features of adolescents with major depression. Biol Psychiatry 36: 573-581.
16. Giedke H, Schwarzler F (2002) Therapeutic use ofsleep deprivation in depression. Sleep Med Rev 6(5): 361-377.
17. Giles D, Jarrett RB, Roffwarg HP, Rush AJ (1987) Reduced rapid eye movement latency: a predictor of recurrence in depression. Neuropsychopharmacology 1: 33-39.
18. Gresham SC, Agnew HW, Williams RL (1965) The sleep ofdepressed patients. Arch Gen Psychiatry 13: 503-507.
19. Hamilton M (1989) Frequency of symptoms in melancholia (depressive illness). Br J Psychiatry 154: 201-206.
20. Hamon M, Cossery JM, Spampinato U, Gozlan H (1986) Are there selective ligands for 5HT1a and 5HT1b receptor binding sites in brain. Trends Pharmacol Sci 7: 336-338.
21. Hendrickse WA, Roffwarg HP, Granneman BD, Orsulak PJ, Armitage R, Cain JW, Battaglia J, DebusJR, Rush AJ (1994) The effects of fluoxetine on the polysomnogram of depressed outpatients: a pilot study. Neuropsychopharmacology 10: 85-91.
22. Hubain PP, Souery D, Jonck L, Staner L, Van Veeren C, Kerkhofs M, Mendlewitz J, Linkowski P (1995) Relationship between the Newcastle scale and sleep polysomno-graphic variables in major depression: a controlled study. Eur Neuropsychopharmacol 5: 129-134.
23. Idzikowski C, Mills FJ, James RJ (1991) A dose-response study examining the effects ofritan-serin on human slow wave sleep. Br J Clin Pharmacol 31 (2): 193-196.
24. Invernizzi R, Belli S, Samanin R (1992) Citalopram's ability to increase the extracellular concentration of serotonin in the dorsal raphe prevents the drug's effects in the frontal cortex. Brain Res 584: 322-324.
25. Kreiss DS, Lucki I (1995) Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5HT measured in vivo. J Pharmacol Exp Ther 284: 866-876.
26. Kupfer DJ, Foster DG (1972) Interval between onset ofsleep and rapid eye movement sleep as an indicator ofdepression. Lancet 2:648-649.
27. Kupfer DJ, Franke E, McEachran AB, Grochocinski VJ (1990) Delta sleep ratio. Abiological correlate of early recurrence in unipolar affective disorder. Arch Gen Psychiatry 47(12): 1100-1105.
28. Kupfer DJ, Ulrich RF, Coble PA, Jarrett DB, Grochocinski V, DomanJ, Matthews G, Borbely AA (1984) Application ofautomated REM and slow wave sleep analysis: II. Testing the assumptions of the two-process model of sleep regulation in normal and depressed subjects. Psychiatry Res 13(4): 335-343.
29. Lauer CJ, Riemann D, Wiegand M, Berger M (1991) From early to late adulthood: changes in EEG sleep of depressed patients and healthy volunteers. Biol Psychiatry 29: 979-993.
30. Lauer CJ, Schreiber W, Holsboer F, Krieg JC (1995) In quest of identifying vulnerability markers for psychiatric disorders by all-night polysomnography. Arch Gen Psychiatry 52: 145-152.
31. Lawlor BA, Newhouse PA, Balkin TJ, Molchan SE, Mellow AM, Murphy DL, Sunderland T. A preliminary study of the effects of nighttime administration of the serotonin agonist, m-CPP, on sleep architecture and behavior in healthy volunteers. Biol Psychiatry 29(3): 281-286.
32. Mendlewicz J, Kempenaers C, de Maertelaer V (1991) Sleep EEG and amitriptyline treatment in depressed inpatients. Biol Psychiatry 30:691-702.
33. Monaca C, Boutrel B, Hen R, Hamon M, Adrien J (2003) 5-HT 1A/1B receptor-mediated effects ofthe selective serotonin reuptake inhibitor, citalopram, on sleep: studies in 5-HT 1A and 5-HT 1B knockout mice. Neuropsychopharmacology 28(5): 850-856.
34. Monti JM, Monti D (2000) Role ofdorsal raphe nucleus serotonin 5HT1a receptor in the regulation of REM sleep. Life Sciences 66: 1999-2012.
35. Rechtschaffen A, Kales A (1968) A manual of standardized terminology, techniques and scoring system for sleep stages in normal subjects. Washington, DC: US Dept of HEW.
36. Reynolds CF, Kupfer DJ (1987) Sleep research in affective illness. Sleep 10: 199-215.
37. Romero L, Bel N, CasanovasJM, Artigas F (1996) Two actions are better than one: avoiding self-inhibition ofserotonergic neurones enhances the effects ofserotonin uptake inhibitors. Int Clin Psychopharmacol 11 (Suppl 4): 1-8.
38. Rush AJ, Armitage R, Gillin JC, et al. (1998) Comparative effects of nefazodone and fluoxetine in outpatients with major depressive disorder. Biol Psychiatry 44:3-14.
39. Sharpley AL, Solomon RA, CowenPJ (1988) Evaluation of first night effect using ambulatory monitoring and automatic sleep stage analysis. Sleep11: 273-276.
40. Shipley JE, Kupfer DJ, Dealy RS, Griffin SJ, Coble PA, McEachran AB, Grochocinski VJ (1984) Differential effects of amitriptyline and of zimelidine on the sleep electroencephalogram ofdepressed patients. Clin Pharmacol Ther 36: 253-259.
41. Shipley JE, Kupfer DJ, Griffin SJ, Dealy RS, Coble PA, McEachran AB, Grochocinski VJ (1985) Comparison of effects of desipramine and amitriptyline on EEG sleep of depressed patients. Psychopharmacology 85: 14-22.
42. Thase ME (1999) Antidepressant treatment of the depressed patient with insomnia. JClin Psychiatry 60(Suppl 17): 28-31.
43. Thase ME (2000) Treatment issues related to sleep and depression. J Clin Psychiatry 61(Suppl 11): 46-50.
44. Thase ME, Simons AD, Reynolds CFIII (1998) Psychobiology correlates of poor response to cognitive behavior therapy: potential indications for antidepressant pharmacotherapy. Psychopharmacol Bull 29(2): 293-301.
45. Vinar O, Vinarova E, Horacek J (1996) Pindolol accelerates the therapeutic action of SSRIs in depression. Homeostasis 37: 93-95.
46. Vogel GW, Buffenstein A, Minter K, Hennessey A (1990) Drug effects on REM sleep and on endogenous depression. Neurosci Biobehav Res 14: 49-63.
47. Vogel GW, Thurmond A, Gibbons P, Sloan K, Walker M (1975) REM sleep reduction effects on depression syndromes. Arch Gen Psychiatry 32 (6): 765-777.
48. Wilson SJ, Bell CJ, Coupland NJ, Nutt DJ (2000) Sleep changes during long-term treatment of depression with fluvoxamine-a home based study. Psychopharmacology 149 (4): 360365.